# Busulfan in Multiple Myeloma

> **NCT00934232** · PHASE1 · TERMINATED · sponsor: **Guido Tricot** · enrollment: 13 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Busulfan

## Key facts

- **NCT ID:** NCT00934232
- **Lead sponsor:** Guido Tricot
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** PI left the institution
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934232, "Busulfan in Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00934232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*